Similar Items: A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activity
- IGF2BP3 inhibition: another home run for RNA-binding protein targeting in hematological malignancies
- NEAT1: a multifaceted long non-coding RNA in multiple myeloma
- The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon: An Analytical Cross-Sectional Study
- Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients with Diabetes Mellitus Following Heart Transplantation: A Meta-analysis
- Change in Effectiveness and Safety Parameters After Initiation of SGLT2 Inhibitors for Post-Transplant Diabetes Mellitus: A Real-World Observational Study
- Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials